移植後的高血壓

Hypertension after Kidney Transplantation

10.6340/KD.2016.28(1).04

陳致中(Chih-Chung Chen)；吳明儒(Ming-Ju Wu)；徐國雄(Kuo-Hsiung Shu)；鄭志雄(Chi-Hung Cheng)

腎臟移植 ； 高血壓 ； 改善全球腎臟病預後組織臨床指引 ； kidney transplantation ； hypertension ； KDIGO guideline

腎臟與透析

28卷1期（2016 / 03 / 01）

14 - 18

繁體中文

對一般大眾而言，控制血壓已證實可預防心血管疾病和延緩慢性腎臟病的進展；0對於慢性腎臟病的病人來說，也有證據顯示控制高血壓可減少蛋白尿和減緩腎功能的惡化。對於腎移植接受者，高血壓的盛行率高，也是心血管疾病和慢性移植腎病變的危險因子。雖然在腎移植接受者的血壓目標值為何還沒定論，藥物的副作用也可能較一般人常見，但在改善全球腎臟病預後組織臨床指引仍建議腎移植接受者應監測並控制血壓。

In general population, there is strong evidence that treatment of hypertension is effective in preventing cardiovascular disease and in retarding the progression of chronic kidney disease. There are also evidences in chronic kidney disease that blood pressure reduction reduces proteinuria and slows the rate of decline in kidney function. The incidence of hypertension in kidney transplantation recipients is high, and hypertension is also a risk factor for cardiovascular disease and chronic allograft injury. Although the optimal target of blood pressure in kidney transplantation recipient is not clear and the adverse effects of pharmacological treatment are likely more common than in the general population, monitor and control blood pressure is still recommended in KDIGO (Kidney Disease: Improving Global Outcomes) guideline.